We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension (CRYSTAL-CO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00771069
Recruitment Status : Completed
First Posted : October 10, 2008
Last Update Posted : December 3, 2010
Sponsor:
Information provided by:

Study Description
Brief Summary:
This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.

Condition or disease
Hypertension

Study Design

Study Type : Observational
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.
Study Start Date : November 2008
Primary Completion Date : March 2009
Study Completion Date : March 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
1
Type II Diabetes Mellitus patients with Complication and Hypertension


Outcome Measures

Primary Outcome Measures :
  1. Attainment rate to the target blood pressure. [ Time Frame: After collecting all Patient Record Form. ]

Secondary Outcome Measures :
  1. Attainment to the target blood pressure will be investigated according to DM related complications. [ Time Frame: After collecting all Patient Record Form. ]
  2. Change in the DBP/SBP value will be investigated according to the DM Complication [ Time Frame: After collecting all Patient Record Form. ]
  3. Treatment pattern and factors that affect BP control [ Time Frame: After collecting all Patient Record Form. ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Type II Diabetes Mellitus patients with Complication and Hypertension
Criteria

Inclusion Criteria:

  • After diagnosed type II DM, patients received treatment for a least 3 years
  • Type II DM patients with hypertension and its complication.
  • Visited out-patients to care center after 1 Jan. 2008

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication
  • Patients stopping BP medication, by physician's order
  • Patients currently enrolled in other clinical studies
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00771069


Locations
Korea, Republic of
Research Site
Bucheon, Gyeonggi, Korea, Republic of
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Guri, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Research Site
Suwon, Gyeonggi, Korea, Republic of
Research Site
Wonju, Kangwon, Korea, Republic of
Research Site
Jeonju, Keollabuk, Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Incheon, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Joonwoo Bahn Astrazenca Korea
More Information

ClinicalTrials.gov Identifier: NCT00771069     History of Changes
Other Study ID Numbers: NIS-CKR-DUM-2008/3
First Posted: October 10, 2008    Key Record Dates
Last Update Posted: December 3, 2010
Last Verified: December 2010

Keywords provided by AstraZeneca:
Hypertension
Type II DM
DM related complication
JNC7
2007 ESH-ESC guidelines
survey

Additional relevant MeSH terms:
Diabetes Mellitus
Hypertension
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
Cardiovascular Diseases